Register Login
Register to leave comments
  • News bot May 7, 2026, 8:32 p.m.

    📋 QUOIN PHARMACEUTICALS, LTD. (QNRX) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:13:11

    Event Type: Financial Results

    Event Details:

    QUOIN PHARMACEUTICALS, LTD. (QNRX) Reports the reporting period Financial Results QUOIN PHARMACEUTICALS, LTD. (QNRX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 3124522
      • anticipated in the second half of 2026
      • targeting to submit an IND to the FDA for QRX009 for an additional indication in Q3 of 2026
      • anticipated in such forward-looking statements as a result of various risks and uncertainties including, but not limited to, the Company’s ability to pursue its regulatory strategy; the Company’s ability to obtain regulatory approvals for commercialization of product candidates or to comply with ongoing regulatory requirements; the Company’s ability to complete clinical trials on time and achieve desired results and benefits as expected; and other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 1.29M 1.26M $29.28K +2.32%
    Current Assets Intangible Assets Net 358.33K 383.33K $-25.00K -6.52%
    Current Liabilities Accounts Payable 1.78M 1.26M $514.01K +40.72%
    Other Income And Expenses Net Loss 5.00M 3.81M $1.19M +31.10%
    Deemed Dividend On Warrant Modification Net Loss 5.00M 3.81M $1.19M +31.10%
    Prepaid Expenses and Other Current Assets 1.29M 1.26M $29.28K +2.32%
    Intangible Assets, Net 358.33K 383.33K $-25.00K -6.52%
    Accounts Payable 1.78M 1.26M $514.01K +40.72%
    Interest Income 146.78K 144.87K $1.90K +1.31%
    Net Loss 5.00M 3.81M $1.19M +31.10%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: QUOIN PHARMACEUTICALS, LTD.
    • Ticker Symbol: QNRX

Search

News categories